Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]

Efzimfotase alfa has shown positive Phase 3 results in children [...]

PolyPid is preparing to submit a New Drug Application for [...]

GSK announced that the European Commission has approved Exdensur (depemokimab) [...]

ViiV Healthcare will present new data from its long-acting and [...]

Compass Pathways has reported that its second pivotal Phase 3 [...]

Boehringer Ingelheim has reported Phase 2 clinical trial results showing [...]

Scancell Holdings has announced that the U.S. Food and Drug [...]

Bicara Therapeutics has selected 1500 mg of ficerafusp alfa as [...]

Doron Therapeutics has dosed the first patients in its Phase [...]